GOODWILL (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2020 |
Jun. 30, 2021 |
Jun. 30, 2020 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Dec. 31, 2018 |
|||||||
GOODWILL (Details) [Line Items] | ||||||||||||
Goodwill impairment | $ 1,682 | $ 1,682 | [1],[2] | [1] | ||||||||
Good will | 18,508 | 18,508 | [2] | 20,190 | $ 18,508 | |||||||
Non-Cannabinoid [Member] | ||||||||||||
GOODWILL (Details) [Line Items] | ||||||||||||
Goodwill impairment | $ 1,682 | 1,682 | 1,682 | |||||||||
Good will | $ 1,682 | |||||||||||
Discounted Future Cash Flow [Member] | ||||||||||||
GOODWILL (Details) [Line Items] | ||||||||||||
Impairment analysis, weighted-average cost of capital | 19.00% | 19.00% | ||||||||||
Impairment analysis, perpetual growth rate | 2.00% | 2.00% | ||||||||||
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Impairment Analysis, Perpetual Growth Rate No definition available.
|
X | ||||||||||
- Definition Impairment Analysis, Weighted-average Cost of Capital No definition available.
|
X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|